SCHEMBL6982284

SCHEMBL6982284

COc1ccc(NS(=O)(=O)c2cc(Br)c(Cl)s2)cc1N1CCNCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.61
HTR7 P34969 3/20 0.60
HTR4 Q13639 3/20 0.60
HTR1A P08908 2/20 0.60
DRD2 P14416 2/20 0.60
HTR1D P28221 2/20 0.60
HTR1B P28222 2/20 0.60
HTR2C P28335 2/20 0.60
ADRA1B P35368 2/20 0.60
DRD3 P35462 2/20 0.60
DRD1 P21728 1/20 0.60
DRD4 P21917 1/20 0.60
HTR2A P28223 1/20 0.60
CYP1A2 P05177 1/20 0.59
ADRB1 P08588 1/20 0.59
CYP3A4 P08684 1/20 0.59
ADRA2A P08913 1/20 0.59
CYP2D6 P10635 1/20 0.59
ADRB3 P13945 1/20 0.59
SLC6A2 P23975 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976513 0.89 HTR6 (0.65) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6971169 0.85 HTR6 (0.66) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6983122 0.84 HTR6 (0.65) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6983543 0.82 HTR6 (0.63) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6975332 0.79 HTR6 (0.80) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6980079 0.79 HTR6 (0.80) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6973742 0.79 HTR6 (0.80) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6976495 0.78 HTR6 (0.92) HTR6HTR7HTR1AHTR2CHTR2B
SCHEMBL15821331 0.77 HTR6 (0.69) HTR6HTR7HTR4HTR1ADRD2
SCHEMBL6972576 0.77 HTR6 (0.85) HTR6HTR7HTR4HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946539-B1 SULPHONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS SMITHKLINE BEECHAM PLC (GB) 2003-08-13 EP claimed
US-6599904-B2 5-HT6 receptor antagonists are believed to be of potential use in the treatment of certain CNS disorders; cognitive memory enhancement SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed